Publication | Closed Access

Spinal cord injury target-immunotherapy with TNF-α autoregulated and feedback-controlled human umbilical cord mesenchymal stem cell derived exosomes remodelled by CRISPR/Cas9 plasmid

Regenerative MedicineGene TherapiesNeuroregenerationSpinal Cord InjuryCrispr/cas9 PlasmidMedicineStem Cell EngineeringImmunologyStem Cell ResearchStem-cell TherapyCrisprStem Cell TherapiesMesenchymal Stem CellTherapeuticsStem CellsCell BiologyGenome Editing